196 related articles for article (PubMed ID: 28620928)
1. The importance of the number of transplanted cells with dipeptidyl peptidase-4 expression on the haematopoietic recovery and lymphocyte reconstitution in patients with multiple myeloma after autologous haematopoietic stem-cell transplantation.
Kopinska A; Krawczyk-Kulis M; Dziaczkowska-Suszek J; Bieszczad K; Jagoda K; Kyrcz-Krzemien S
Hematol Oncol; 2017 Jun; 35(2):225-231. PubMed ID: 28620928
[TBL] [Abstract][Full Text] [Related]
2. Effect of transplanted cells with CD184 and CD26 expressions and reconstitution of CD3+ lymphocyte population on long-term survival after autologous hematopoietic stem cell transplantation for multiple myeloma.
Kopinska A; Krawczyk-Kulis M; Wieczorkiewicz-Kabut A; Koclega A; Jagoda K; Dziaczkowska-Suszek J; Helbig G
Exp Hematol; 2023 Nov; 127():52-58.e1. PubMed ID: 37666354
[TBL] [Abstract][Full Text] [Related]
3. Apheresis-related enrichment of CD26++ T lymphocytes: phenotypic characterization and correlation with unfavorable outcome in autologous hematopoietic progenitor cell transplantation.
Hildebrandt M; Dijkstra D; Gollasch H; Daemen K; Stevanovic-Meyer M; Ludwig WD
Transfusion; 2012 Apr; 52(4):765-76. PubMed ID: 21950525
[TBL] [Abstract][Full Text] [Related]
4. CD26 expression in donor stem cell harvest and its correlation with engraftment in human haematopoietic stem cell transplantation: potential predictor of early engraftment.
Prabhash K; Khattry N; Bakshi A; Karandikar R; Joshi A; Kannan S; Sastry PSRK; Parikh P; Kode JA
Ann Oncol; 2010 Mar; 21(3):582-588. PubMed ID: 19759183
[TBL] [Abstract][Full Text] [Related]
5. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients.
Lima-Júnior JR; Arruda LCM; Gonçalves MS; Dias JBE; Moraes DA; Covas DT; Simões BP; Oliveira MC; Malmegrim KCR
Rheumatology (Oxford); 2021 Dec; 60(12):5538-5548. PubMed ID: 33724344
[TBL] [Abstract][Full Text] [Related]
6. CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients.
Hicks C; Isaacs A; Wong R; Chong BH
Ann Hematol; 2011 May; 90(5):547-55. PubMed ID: 20957366
[TBL] [Abstract][Full Text] [Related]
7. Immunological reconstitution after autologous stem cell transplantation in patients with refractory systemic autoimmune diseases.
Szodoray P; Varoczy L; Papp G; Barath S; Nakken B; Szegedi G; Zeher M
Scand J Rheumatol; 2012 Mar; 41(2):110-5. PubMed ID: 21936606
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal cells improve early lymphocyte recovery and T cell reconstitution after autologous hematopoietic stem cell transplantation in patients with malignant lymphomas.
Batorov EV; Shevela EY; Tikhonova MA; Batorova DS; Ushakova GY; Sizikova SA; Sergeevicheva VV; Gilevich AV; Kryuchkova IV; Ostanin AA; Chernykh ER
Cell Immunol; 2015 Oct; 297(2):80-6. PubMed ID: 26227214
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma.
Rueff J; Medinger M; Heim D; Passweg J; Stern M
Biol Blood Marrow Transplant; 2014 Jun; 20(6):896-9. PubMed ID: 24631739
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.
Fletcher MA; Zeng XR; Maher K; Levis S; Hurwitz B; Antoni M; Broderick G; Klimas NG
PLoS One; 2010 May; 5(5):e10817. PubMed ID: 20520837
[TBL] [Abstract][Full Text] [Related]
12. Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.
Darlington PJ; Stopnicki B; Touil T; Doucet JS; Fawaz L; Roberts ME; Boivin MN; Arbour N; Freedman MS; Atkins HL; Bar-Or A
Front Immunol; 2018; 9():834. PubMed ID: 29867923
[TBL] [Abstract][Full Text] [Related]
13. Immune reconstitution and production of intracellular cytokines in T lymphocyte populations following autologous peripheral blood stem cell transplantation.
Schlenke P; Sheikhzadeh S; Weber K; Wagner T; Kirchner H
Bone Marrow Transplant; 2001 Aug; 28(3):251-7. PubMed ID: 11535992
[TBL] [Abstract][Full Text] [Related]
14. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution.
Douek DC; Vescio RA; Betts MR; Brenchley JM; Hill BJ; Zhang L; Berenson JR; Collins RH; Koup RA
Lancet; 2000 May; 355(9218):1875-81. PubMed ID: 10866444
[TBL] [Abstract][Full Text] [Related]
15. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
16. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation.
Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E
Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353
[TBL] [Abstract][Full Text] [Related]
17. Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
Hicks C; Wong R; Manoharan A; Kwan YL
Ann Hematol; 2007 Aug; 86(8):591-8. PubMed ID: 17492259
[TBL] [Abstract][Full Text] [Related]
18. CD26+ Cord Blood Mononuclear Cells Significantly Produce B, T, and NK Cells.
Aliyari Z; Alemi F; Brazvan B; Tayefi Nasrabadi H; Nozad Charoudeh H
Iran J Immunol; 2015 Mar; 12(1):16-26. PubMed ID: 25784094
[TBL] [Abstract][Full Text] [Related]
19. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Klaus J; Herrmann D; Breitkreutz I; Hegenbart U; Mazitschek U; Egerer G; Cremer FW; Lowenthal RM; Huesing J; Fruehauf S; Moehler T; Ho AD; Goldschmidt H
Eur J Haematol; 2007 Jan; 78(1):21-8. PubMed ID: 17042762
[TBL] [Abstract][Full Text] [Related]
20. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
